on 09 Apr 2024
Last Applicant/ Owned by
1-6-1 Ohtemachi, Chiyoda-ku
Tokyo
JP
100-0004
Serial Number
97896372 filed on 19th Apr 2023
Registration Number
N/A
Correspondent Address
Kaushal Odedra
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
The color(s) blue and orange is/are claimed as a feature of the mark. HULIO THREE HUNDRED SIXTY; HULIO THREE SIX ZERO; HULIO THREE SIXTY Pharmaceutical preparations for treatment of autoimmune and inflammatory diseases; Pharmaceutical preparations comprised of a monoclonal antibody to a tumor necrosis factor alpha for treatment of autoimmune and inflammatory diseases The mark consists of the stRead More
Pharmaceutical preparations for treatment of autoimmune and inflammatory diseases; Pharmaceutical preparations comprised of a monoclonal antibody to a tumor necrosis factor alpha for treatment of autoimmune and inflammatory diseases
No 97896372
No Service/Collective Mark
No TM23-403a
No
No
No
No
No
No
No
No
The mark consists of the stylized word "HULIO" in blue and the stylized numbers "360" with "3" in shades of blue, "6" in shades of blue and orange, and "0" in shades of orange. White represents background, outlining, shading and/or transparent areas and is not part of the mark.
Status Date | Action Taken |
---|---|
09th Apr 2024 | PUBLISHED FOR OPPOSITION |
09th Apr 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
20th Mar 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
01st Mar 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
26th Feb 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
26th Feb 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
26th Feb 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
23rd Jan 2024 | NON-FINAL ACTION WRITTEN |
23rd Jan 2024 | NON-FINAL ACTION E-MAILED |
23rd Jan 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |